PT410 – Nick Kadysh – Manufacturing MDMA and Why Creating MDMA Analogs Is So Important
Psychedelics Today
Psychedelics Today, LLC
4.6 • 598 Ratings
🗓️ 16 May 2023
⏱️ 64 minutes
🧾️ Download transcript
Summary
In this episode, Joe interviews Nick Kadysh: Founder and CEO of PharmAla Biotech and member of the board of directors for The Canadian Psychedelic Businesses Association.
PharmAla Biotech is a Toronto-based Life Sciences company with two focuses: contracting with manufacturers to provide researchers with GMP MDMA (created under Good Manufacturing Practice regulations), and creating and researching novel analogs of MDMA. And just today, they announced that Health Canada has authorized them (and their distribution partner, Shaman Pharma) to supply their LaNeo™ MDMA for the treatment of a patient under Canada's Special Access Program – the first time this has happened in Canada.
He discusses the creation of PharmAla and why their model changed from primarily researching analogs to manufacturing; why they're operating out of Canada and using manufacturers instead of running the lab themselves; the excitement around Australia's recent about-face on MDMA and psilocybin-assisted therapy; the bureaucracy of U.S. drug policy and how much a broken supply chain affects the whole industry; bad IP and companies filing rapid fire patents; why creating new analogs of MDMA is so important; and why the psychedelic space needs to bring culture along with us.
He also talks about Spravato, cannabis and risks of cancer, THC nasal sprays, and research he's most excited about: that MDMA seems to alleviate dyskinesia caused from Parkinson's disease, and that MDMA could improve social anxiety in people with autism. He's aiming to run a clinical trial and believes they have developed a safe MDMA analog that the autistic community will respond to very well.
www.psychedelicstoday.com
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hey everyone, Minesh Gern, aka the psychedelic scientist here. |
| 0:04.6 | Are you fascinated by the exciting emerging research on how psychedelics affect the brain? |
| 0:09.6 | Do you wish you had a stronger background so you can engage with the latest findings and also |
| 0:13.9 | apply the insights in a practical way? Well, look no further than our brand new eight-week |
| 0:19.2 | live taught online course entitled |
| 0:21.7 | Psychedelic Neuroscience Demystified, how psychedelics alter consciousness and produce therapeutic effects. |
| 0:28.7 | This course starts from the very basics and guides students on a very accessible |
| 0:32.5 | but in-depth tour of the fascinating world of psychedelic neuroscience. |
| 0:36.9 | We focus on serotonergic psychedelics, |
| 0:39.3 | such as psilocybin, LSD, and DMT, as well as ketamine and MDMA. You will learn all about |
| 0:45.5 | how each of these different drugs affect brain receptors and how that leads to various changes |
| 0:50.5 | in brain activity that underlie their potent psychological effects and their ability to |
| 0:55.7 | help treat mental health conditions. Along the way, we'll also a deep dive into how psychedelics |
| 1:00.6 | boost neuroplasticity, scientific research relevant to set and setting, how psychedelics synergized |
| 1:06.9 | with practices such as meditation, and much more. So whether you're a mental health professional, researcher, or an interested layperson, |
| 1:14.4 | this course is perfect to give you a solid footing in psychedelic neuroscience. |
| 1:18.9 | Classes start on May 17th, and you can find out more information and enroll at |
| 1:23.0 | psychedelic education center.com. |
| 1:25.8 | Come join us at the forefront of this fascinating topic. |
| 1:40.8 | Hey, everybody. Welcome back to psychedelics today. |
| 1:43.1 | Joe Moore here. |
| 1:44.1 | Today on the show, we have Nick Kadesh from Farmala. I believe Farmala is set up to be major MDMA manufacturer worldwide. It's going to be an interesting landscape, everybody. But yeah, Nick and I jump into why he started Farmla. Why is there a need to manufacture MDMA at scale? |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Psychedelics Today, LLC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Psychedelics Today, LLC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.